Cargando…

Evaluation of in vitro susceptibility of fosfomycin among Enterobacteriaceae isolates from urine cultures: A study from Puducherry

INTRODUCTION: The increasing drug resistance among Gram-negative uropathogens and a lack of effective oral antibiotics have limited the therapeutic options available for urinary tract infections (UTIs). This shortage of newer antibiotics has paved the way for considering the use of older antibiotics...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sreenivasan, Srirangaraj, Kali, Arunava, Pravin Charles, M. V., Kunigal, Seetha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771322/ https://www.ncbi.nlm.nih.gov/pubmed/31579232 http://dx.doi.org/10.4103/JLP.JLP_27_19

Ejemplares similares

Antibacterial synergy of curcumin with antibiotics against biofilm producing clinical bacterial isolates
por: Kali, Arunava, et al.
Publicado: (2016)

Multidrug Resistant Shigella flexneri Infection Simulating Intestinal Intussusception
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2016)

2062. Evaluation of Susceptibility Testing Methods for Fosfomycin Against Enterobacteriaceae and Pseudomonas aeruginosa
por: De La Cadena, Elsa Piedad, et al.
Publicado: (2018)

135 Fosfomycin Susceptibilities Among Uropathogenic Extended Spectrum Beta-Lactamase-producing Enterobacteriacea
por: Abbo, Lilian, et al.
Publicado: (2014)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Mobile fosfomycin resistance genes in Enterobacteriaceae—An increasing threat
por: Zurfluh, Katrin, et al.
Publicado: (2020)

Candiduria—Study of Virulence Factors and Its Antifungal Susceptibility Pattern in Tertiary Care Hospital
por: Pramodhini, Subramanian, et al.
Publicado: (2021)

2396. Fosfomycin Resistance Among Carbapenem-Resistant Enterobacteriaceae Clinical Isolates in Connecticut, 2017
por: Snayd, Mary, et al.
Publicado: (2018)

Performance of chromogenic media for Candida in rapid presumptive identification of Candida species from clinical materials
por: Pravin Charles, M. V., et al.
Publicado: (2015)

Frequency of colistin and fosfomycin resistance in carbapenem-resistant Enterobacteriaceae from a tertiary care hospital in Karachi
por: Qamar, Salima, et al.
Publicado: (2017)

Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs
por: Jariyapamornkoon, Nattha, et al.
Publicado: (2023)

Fosfomycin Dosing Regimens based on Monte Carlo Simulation for Treated Carbapenem-Resistant Enterobacteriaceae Infection
por: Kanchanasurakit, Sukrit, et al.
Publicado: (2020)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections
por: Amladi, Anushree Ulhas, et al.
Publicado: (2019)

Fosfomycin and Comparator Activity Against Select Enterobacteriaceae, Pseudomonas, and Enterococcus Urinary Tract Infection Isolates from the United States in 2012
por: Keepers, Tiffany R., et al.
Publicado: (2017)

In vitro antimicrobial susceptibility of fosfomycin against organisms isolated from various clinical specimens: a multicentre trial from Kolkata
por: Chakraborty, A, et al.
Publicado: (2015)

In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004–2012)
por: Lai, Bei, et al.
Publicado: (2014)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

EndNote as document manager for summative assessment
por: Kali, A, et al.
Publicado: (2016)

Comparing Absolute Lymphocyte Count to Total Lymphocyte Count, as a CD4 T Cell Surrogate, to Initiate Antiretroviral Therapy
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2011)

Are Police Personnel in Puducherry Healthy? Findings from “Partners in Prevention” Programme in Puducherry, India
por: Ravikumar, T. S., et al.
Publicado: (2017)

In vitro activity of fosfomycin against Campylobacter isolates from poultry and wild birds
por: Wei, Bai, et al.
Publicado: (2018)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2020)

Antimicrobial susceptibility of bacteria isolated from urine cultures in Southern Turkey
por: Baran, Caner, et al.
Publicado: (2022)

Activity of temocillin and 15 other agents, including fosfomycin and colistin, against Enterobacteriaceae in Hong Kong
por: Ip, Margaret, et al.
Publicado: (2017)

Characterization of predictors of ESBL‐producing enterobacteriaceae in urine cultures of emergency department patients
por: Saadi, Raghad, et al.
Publicado: (2021)

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
por: Martín-Gutiérrez, Guillermo, et al.
Publicado: (2020)

Hepcidin - A novel biomarker with changing trends
por: Kali, Arunava, et al.
Publicado: (2015)

671. Same Day Identification of Enterobacteriaceae Directly from Urine Samples
por: Kon, Shelley E, et al.
Publicado: (2020)

Susceptibility and Virulence of Enterobacteriaceae Isolated from Urinary Tract Infections in Benin
por: Assouma, Funkè F., et al.
Publicado: (2023)

1525. Evaluation of Clinical Outcomes With Fosfomycin for E. coli and Non-E. coli Enterobacteriaceae Urinary Tract Infections
por: Lee, Tiffany, et al.
Publicado: (2018)

Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
por: Bielen, Luka, et al.
Publicado: (2019)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

Assessing the Emergence of Resistance in vitro and Invivo: Linezolid Combined with Fosfomycin Against Fosfomycin-Sensitive and Resistant Enterococcus
por: Li, Yaowen, et al.
Publicado: (2022)

1222. Fosfomycin Susceptibility Testing using the new ETEST(®)FO
por: Halimi, Diane, et al.
Publicado: (2020)

Fosfomycin susceptibility of uropathogens at Charlotte Maxeke Johannesburg Academic Hospital
por: Mothibi, Lesego M., et al.
Publicado: (2020)

Fosfomycin Susceptibility Testing Using Commercial Agar Dilution Test
por: Croughs, Peter D., et al.
Publicado: (2022)

Extended-spectrum β-lactamase producing Klebsiella pneumoniae from blood cultures in Puducherry, India
por: Parveen, R.M., et al.
Publicado: (2011)

Assessment of Readiness Toward Flipped Learning Among Novice Nursing Students on Fundamental Nursing Care in Puducherry, South India
por: Shanmugapriya, Kannan, et al.
Publicado: (2023)

Genomic analysis of Fosfomycin resistance in multi-drug resistant uropathogens and comparison of in-vitro susceptibility methods uropathogens
por: Bir, Raunak, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fhfth6p3jpngdlgnqeapv055l8